A pretty serious presentation with no hint of any smiles from TK. I gained the impression from body language that he really wished he didn’t need to go through the exercise.
Nonetheless a couple of comments were informative.
“The (Confirmatory) clinical study is essentially a carbon copy of the one we ran before. … Very, very similar data to what we had before, so there is a very high chance of success.”
“We’re talking about Pfizer acquiring the Company, so the Company would then become part of Pfizer and really give us the opportunity to tale this technology to the World.” (i.e. the reduction of uncertainty for the Company takes priority over the interest of shareholders).
- Forums
- ASX - By Stock
- RAP
- Ann: Increased Scheme Consideration from Pfizer
Ann: Increased Scheme Consideration from Pfizer, page-325
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
RAP (ASX) Chart |
Day chart unavailable